(Q51503680)

English

Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice.

scientific article published in July 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/9720634

Behavioural pharmacological characteristics of honokiol, an anxiolytic agent present in extracts of Magnolia bark, evaluated by an elevated plus-maze test in mice. (English)

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/9720634

1 reference

based on heuristic

inferred from title

elevated plus maze

1 reference

based on heuristic

inferred from title

author name string

Kuribara H

1

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/9720634

Stavinoha WB

2

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/9720634

Maruyama Y

3

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/9720634

publication date

1 July 1998

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/9720634

Journal of Pharmacy and Pharmacology

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/9720634

50

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/9720634

819-826

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/9720634

7

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/9720634

Caffeine-induced anxiogenesis: the role of adenosine, benzodiazepine and noradrenergic receptors

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

The neuropharmacology of various diazepam antagonists

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

The cholecystokinin hypothesis of anxiety and panic disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

A dose-ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

Increased anxiogenic effects of caffeine in panic disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

Biological actions of cholecystokinin

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

GABAergic influences on plus-maze behaviour in mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

Use of the elevated plus maze in the search for novel anxiolytic agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Preliminary findings.

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics.

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

Anxiolytic activity of adenosine receptor activation in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

Differential effects of flumazenil in alcoholic and nonalcoholic cirrhotic patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

Effects of benzodiazepine receptor antagonist, flumazenil, on antinociceptive and behavioural responses to the elevated plus-maze in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

The use of a plus-maze to measure anxiety in the mouse

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects.

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

Identification of magnolol and honokiol as anxiolytic agents in extracts of saiboku-to, an oriental herbal medicine

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

The effects of compounds related to gamma-aminobutyrate and benzodiazepine receptors on behavioural responses to anxiogenic stimuli in the rat: punished barpressing

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

Evidence for an involvement of the brain cholecystokinin B receptor in anxiety

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

Pharmacokinetics of honokiol after intravenous administration in rats assessed using high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

On the significance of cholecystokinin receptors in panic disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

Current benzodiazepine issues.

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

Behavioral, biochemical, and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.1998.TB07146.X

21 January 2018

Identifiers

10.1111/J.2042-7158.1998.TB07146.X

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/9720634

1 reference

Europe PubMed Central

6 April 2018

http://europepmc.org/abstract/MED/9720634

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51503680&oldid=1245447049"